Prestige Biologics Co Ltd
KOSDAQ:334970
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Prestige Biologics Co Ltd
KOSDAQ:334970
|
KR |
|
L
|
Lloyds Banking Group PLC
DUS:LLD
|
UK |
|
T
|
TPBI PCL
SET:TPBI
|
TH |
|
Lithia Motors Inc
F:LMO
|
US |
|
Tokai Carbon Co Ltd
OTC:TKCBF
|
JP |
Intrinsic Value
Is Prestige Biologics Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Prestige Biologics Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Prestige Biologics Co Ltd looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with Prestige Biologics Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Prestige Biologics Does
Prestige Biologics is a South Korean biopharmaceutical services company that helps drug makers develop and manufacture biologic medicines. Its work is centered on contract development and manufacturing, so it does not mainly sell its own branded drugs. Instead, it provides the technical know-how, facilities, and regulated production process needed to turn a biologic drug concept into something that can be made reliably for testing or commercial use.
- Headquarters
- Korea KR
- Employees
- 199
- IPO date
- Mar 11, 2021
Earnings Waterfall
Prestige Biologics Co Ltd
The intrinsic value for Prestige Biologics Co Ltd (334970) under the Base Case is hidden KRW.
Compared with the current market price of 1 260 KRW, the stock appears hidden.